Aditxt, Inc. Payments for Tenant Improvements
Aditxt, Inc. (ADTX) reported Payments for Tenant Improvements of $87.93 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForTenantImprovements · last filed 2023-11-14
- Aditxt, Inc. payments for tenant improvements for the quarter ending 2022-09-30 was -$127.24K.
| Period end | Payments for Tenant Improvements 3 month | Payments for Tenant Improvements 6 month | Payments for Tenant Improvements 9 month |
|---|---|---|---|
| 2022-09-30 | -$127.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $87.93K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $215.17K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |